Page last updated: 2024-11-05

tranexamic acid and Transfusion Reaction

tranexamic acid has been researched along with Transfusion Reaction in 22 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Transfusion Reaction: Complications of BLOOD TRANSFUSION. Included adverse reactions are common allergic and febrile reactions; hemolytic (delayed and acute) reactions; and other non-hemolytic adverse reactions such as infections and adverse immune reactions related to immunocompatibility.

Research Excerpts

ExcerptRelevanceReference
" There have been many changes in the management of massive hemorrhage, for example, the administration of the tranexamic acid and the use of balanced transfusion ratio."4.93[Management of bleeding and coagulopathy following major trauma]. ( Etxaniz, A; Pita, E, 2016)
" The ongoing trials create six new comparisons: tranexamic acid (tablet + injection) versus placebo; intravenous tranexamic acid versus oral tranexamic acid; topical tranexamic acid versus oral tranexamic acid; different intravenous tranexamic acid dosing regimes; topical tranexamic acid versus topical fibrin glue; and fibrinogen (injection) versus placebo."3.01Pharmacological interventions for the prevention of bleeding in people undergoing definitive fixation or joint replacement for hip, pelvic and long bone fractures. ( Brunskill, SJ; Champaneria, R; Dorée, C; Estcourt, LJ; Geneen, LJ; Gibbs, VN; Novak, A; Palmer, AJ; Raval, P, 2023)
"Several methods reportedly reduce postoperative blood loss and avoid homologous blood transfusion with traditional TKA approaches, but it is unclear these reductions apply to a minimally invasive technique."2.76Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial. ( Charoencholvanich, K; Siriwattanasakul, P, 2011)
"Tranexamic acid (TXA) is an antifibrinolytic agent that reduces bleeding and transfusion in a broad number of adult and pediatric surgeries, as well as in trauma and obstetrics."2.61Tranexamic acid and perioperative bleeding in children: what do we still need to know? ( Faraoni, D; Goobie, SM, 2019)
"Tranexamic acid was introduced during these procedures in 2006."1.43Use of Tranexamic Acid Is Associated with Reduced Blood Product Transfusion in Complex Skull Base Neurosurgical Procedures: A Retrospective Cohort Study. ( Akagami, R; Flexman, AM; Mebel, D, 2016)
"The incidence of symptomatic deep vein thrombosis and pulmonary embolism was evaluated."1.43Tranexamic Acid Can Be Administered to Arthroplasty Patients Who Receive Aspirin for Venous Thromboembolic Prophylaxis. ( Chen, AF; Heller, S; Parvizi, J; Secrist, E; Shahi, A, 2016)
"Blood conservation; the area of greatest clinical variability was seen in dosing regimes for Tranexamic acid."1.37Blood conservation and pain control in scoliosis corrective surgery: an online survey of UK practice. ( Bird, S; McGill, N, 2011)

Research

Studies (22)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (13.64)29.6817
2010's18 (81.82)24.3611
2020's1 (4.55)2.80

Authors

AuthorsStudies
Gibbs, VN1
Geneen, LJ1
Champaneria, R1
Raval, P1
Dorée, C1
Brunskill, SJ1
Novak, A1
Palmer, AJ1
Estcourt, LJ1
Cybulska, P1
Goss, C1
Tew, WP1
Parameswaran, R1
Sonoda, Y1
Goobie, SM1
Faraoni, D1
Muñoz Gómez, M2
Páramo Fernández, JA2
Engelbrecht, S1
Wood, EM1
Cole-Sinclair, MF1
Maciel, JD1
Gifford, E1
Plurad, D1
de Virgilio, C1
Bricker, S1
Bongard, F1
Neville, A1
Smith, J1
Putnam, B1
Kim, D1
Gao, F1
Sun, W1
Guo, W1
Li, Z1
Wang, W1
Cheng, L1
Etxaniz, A1
Pita, E1
Bisbe Vives, E1
Basora Macaya, M1
García Erce, JA1
Gómez Luque, A1
Leal-Noval, SR1
Colomina, MJ1
Comin Colet, J1
Contreras Barbeta, E1
Cuenca Espiérrez, J1
Garcia de Lorenzo Y Mateos, A1
Gomollón García, F1
Izuel Ramí, M1
Moral García, MV1
Montoro Ronsano, JB1
Pereira Saavedra, A1
Quintana Diaz, M1
Remacha Sevilla, Á1
Salinas Argente, R1
Sánchez Pérez, C1
Tirado Anglés, G1
Torrabadella de Reinoso, P1
Bagsby, DT1
Samujh, CA1
Vissing, JL1
Empson, JA1
Pomeroy, DL1
Malkani, AL1
Mebel, D1
Akagami, R1
Flexman, AM1
Kopanidis, P1
Hardidge, A1
McNicol, L1
Tay, S1
McCall, P1
Weinberg, L1
Heller, S1
Secrist, E1
Shahi, A1
Chen, AF1
Parvizi, J1
Tzatzairis, TK1
Drosos, GI1
Kotsios, SE1
Ververidis, AN1
Vogiatzaki, TD1
Kazakos, KI1
Soroceanu, A1
Oren, JH1
Smith, JS1
Hostin, R1
Shaffrey, CI1
Mundis, GM1
Ames, CP1
Burton, DC1
Bess, S1
Gupta, MC1
Deviren, V1
Schwab, FJ1
Lafage, V1
Errico, TJ1
Rosencher, N1
Bellamy, L1
Chabbouh, T1
Arnaout, L1
Ozier, Y1
Bird, S1
McGill, N1
Anderson, L1
Charoencholvanich, K1
Siriwattanasakul, P1
Watts, CD1
Pagnano, MW1
Pleym, H1
Katz, E1
Gaitini, L1
Samri, M1
Egoz, N1
Fergusson, D1
Laupacis, A1

Clinical Trials (9)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Tranexamic Acid for Blood Loss Minimization in Endoscopic Pituitary Surgery: A Double-Blind Randomized Controlled Trial[NCT04863339]Phase 20 participants (Actual)Interventional2022-03-31Withdrawn (stopped due to Challenges in recruitment)
Efficacy of Tranexamic Acid in Femoral Shaft Fractures Osteosynthesis; A Double Blind Randomized Controlled Trial[NCT04803591]Phase 40 participants (Actual)Interventional2021-08-01Withdrawn (stopped due to Not approved by Ethics Commettee)
Role of Topical Tranexamic Acid in Total Hip Arthroplasty[NCT01866943]Phase 241 participants (Actual)Interventional2011-11-30Terminated
Peri-articular Tranexamic Acid Injection in Total Knee Arthroplasty: A Randomized Controlled Trial[NCT02829346]Phase 260 participants (Actual)Interventional2012-10-31Completed
Evaluation of Efficacy and Safety of Perioperative Tranexamic Acid During Primary Total Knee Arthroplasty: A Randomized, Clinical Trial[NCT05919615]100 participants (Actual)Interventional2021-07-15Completed
Serial Use of Intravenous and Oral Tranexamic Acid in Primary Total Knee Arthroplasty Patients: A Randomized Controlled Study[NCT03109652]Phase 4144 participants (Anticipated)Interventional2017-07-10Recruiting
Evaluation of the Pharmacokinetic Profile of Tranexamic Acid, After Injection in a Knee Neo-articulation.[NCT02319915]Early Phase 114 participants (Actual)Interventional2015-02-18Completed
Evaluation of the Use of Tranexamic Acid in Tibial Osteotomies: a Randomised Controlled Clinical Trial.[NCT04785651]84 participants (Anticipated)Interventional2021-02-22Recruiting
Efficacy and Safety of Erythropoietin And/Or Intravenous Iron Sucrose For Treatment of Anemia In Hip and Knee Arthroplasty: A Single-center Retrospective Study[NCT03917394]780 participants (Anticipated)Observational2019-04-24Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Estimated Blood Loss

Estimated Blood Loss defined as Pre Op Hgb mins the Post Op Day two Hgb. (NCT01866943)
Timeframe: Pre Op, Post Op Day 2

InterventionHemoglobin (grams/deciliter) (Mean)
Baseline Population2.93

Harris Hip Scores

Standardized questionnaire that measures clinical function related to the hip. Total potential range is from 4.0 - 96.0. A higher score indicates a more favorable clinical outcome. (NCT01866943)
Timeframe: 2 week

Interventionunits on a scale (Mean)
All Study Participants65.76

Harris Hip Scores

Standardized questionnaire that measures clinical function related to the hip. Total potential range is from 4.0 - 96.0. A higher score indicates a more favorable clinical outcome. (NCT01866943)
Timeframe: 6 week

Interventionunits on a scale (Mean)
All Study Participants81.77

Harris Hip Scores

Standardized questionnaire that measures clinical function related to the hip. Total potential range is from 4.0 - 96.0. A higher score indicates a more favorable clinical outcome. (NCT01866943)
Timeframe: Preoperative

Interventionunits on a scale (Mean)
All Study Participants58.34

Mid Thigh Circumference

Measurement of the thigh at the half way point between the prominence of the greater trochanter and the lateral epicondyle of the femur. No data recorded at 2 weeks or 6 weeks for this study population. (NCT01866943)
Timeframe: Pre Op

Interventioncentimeters (Mean)
Baseline Population52.99

Reviews

6 reviews available for tranexamic acid and Transfusion Reaction

ArticleYear
Pharmacological interventions for the prevention of bleeding in people undergoing definitive fixation or joint replacement for hip, pelvic and long bone fractures.
    The Cochrane database of systematic reviews, 2023, 06-05, Volume: 6

    Topics: Arthroplasty, Replacement; Fibrinogen; Fractures, Bone; Hemorrhage; Hemostatics; Humans; Myocardial

2023
Indications for and complications of transfusion and the management of gynecologic malignancies.
    Gynecologic oncology, 2017, Volume: 146, Issue:2

    Topics: Acute Lung Injury; Anemia; Antifibrinolytic Agents; Blood Loss, Surgical; Erythrocyte Transfusion; F

2017
Tranexamic acid and perioperative bleeding in children: what do we still need to know?
    Current opinion in anaesthesiology, 2019, Volume: 32, Issue:3

    Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Child; Dose-Response Relationship,

2019
[Management of bleeding and coagulopathy following major trauma].
    Revista espanola de anestesiologia y reanimacion, 2016, Volume: 63, Issue:5

    Topics: Blood Coagulation Disorders; Hemorrhage; Humans; Multiple Trauma; Tranexamic Acid; Transfusion React

2016
[Blood conservation approaches in orthopedic surgery].
    Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, 2008, Volume: 15, Issue:5

    Topics: Anemia; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Blood Transfusion, Autologous; Drug Admi

2008
Minimising blood loss and transfusion in contemporary hip and knee arthroplasty.
    The Journal of bone and joint surgery. British volume, 2012, Volume: 94, Issue:11 Suppl A

    Topics: Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bl

2012

Trials

3 trials available for tranexamic acid and Transfusion Reaction

ArticleYear
Topical Administration of Tranexamic Acid Plus Diluted-Epinephrine in Primary Total Knee Arthroplasty: A Randomized Double-Blinded Controlled Trial.
    The Journal of arthroplasty, 2015, Volume: 30, Issue:8

    Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Double-Blin

2015
Intravenous vs Topical Tranexamic Acid in Total Knee Arthroplasty Without Tourniquet Application: A Randomized Controlled Study.
    The Journal of arthroplasty, 2016, Volume: 31, Issue:11

    Topics: Administration, Intravenous; Administration, Topical; Aged; Antifibrinolytic Agents; Arthroplasty, R

2016
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011
Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial.
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:10

    Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Bl

2011

Other Studies

13 other studies available for tranexamic acid and Transfusion Reaction

ArticleYear
[Intravenous administration of tranexamic acid to decrease bleeding and transfusion in knee and hip prosthetic surgery: is it safe and cost-effective?].
    Medicina clinica, 2013, Sep-07, Volume: 141, Issue:5

    Topics: Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Cost-Benefit

2013
Clinical transfusion practice update: haemovigilance, complications, patient blood management and national standards.
    The Medical journal of Australia, 2013, Sep-16, Volume: 199, Issue:6

    Topics: Acute Lung Injury; Anticoagulants; Antifibrinolytic Agents; Australia; Blood Transfusion; Clinical P

2013
The impact of a massive transfusion protocol on outcomes among patients with abdominal aortic injuries.
    Annals of vascular surgery, 2015, Volume: 29, Issue:4

    Topics: Abdominal Injuries; Accidents, Traffic; Adolescent; Adult; Antifibrinolytic Agents; Aorta, Abdominal

2015
Forum for debate: Safety of allogeneic blood transfusion alternatives in the surgical/critically ill patient.
    Medicina intensiva, 2015, Volume: 39, Issue:9

    Topics: Anemia; Antifibrinolytic Agents; Aprotinin; Blood Coagulation Factors; Blood Transfusion; Clinical T

2015
Tranexamic Acid Decreases Incidence of Blood Transfusion in Simultaneous Bilateral Total Knee Arthroplasty.
    The Journal of arthroplasty, 2015, Volume: 30, Issue:12

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfus

2015
Use of Tranexamic Acid Is Associated with Reduced Blood Product Transfusion in Complex Skull Base Neurosurgical Procedures: A Retrospective Cohort Study.
    Anesthesia and analgesia, 2016, Volume: 122, Issue:2

    Topics: Antifibrinolytic Agents; Blood Transfusion; Cohort Studies; Erythrocyte Transfusion; Female; Hemoglo

2016
Perioperative blood management programme reduces the use of allogenic blood transfusion in patients undergoing total hip and knee arthroplasty.
    Journal of orthopaedic surgery and research, 2016, Feb-29, Volume: 11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia; Antifibrinolytic Agents; Arthroplasty, Replaceme

2016
Tranexamic Acid Can Be Administered to Arthroplasty Patients Who Receive Aspirin for Venous Thromboembolic Prophylaxis.
    The Journal of arthroplasty, 2016, Volume: 31, Issue:7

    Topics: Aged; Antifibrinolytic Agents; Arthroplasty; Aspirin; Blood Loss, Surgical; Cohort Studies; Female;

2016
Effect of Antifibrinolytic Therapy on Complications, Thromboembolic Events, Blood Product Utilization, and Fusion in Adult Spinal Deformity Surgery.
    Spine, 2016, Jul-15, Volume: 41, Issue:14

    Topics: Adult; Aged; Aminocaproic Acid; Antifibrinolytic Agents; Blood Loss, Surgical; Female; Humans; Male;

2016
Blood conservation and pain control in scoliosis corrective surgery: an online survey of UK practice.
    Paediatric anaesthesia, 2011, Volume: 21, Issue:1

    Topics: Adolescent; Analgesia, Epidural; Analgesics, Opioid; Anesthesia; Anticoagulants; Antifibrinolytic Ag

2011
Blood conservation in cardiac surgery.
    Journal of perioperative practice, 2010, Volume: 20, Issue:12

    Topics: Algorithms; Aprotinin; Blood Loss, Surgical; Blood Substitutes; Blood Transfusion; Cardiac Surgical

2010
[Drugs to reduce transfusion needs during surgery].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2008, Apr-03, Volume: 128, Issue:7

    Topics: Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Blood Transfusion, Auto

2008
The use of technologies to decrease peri-operative allogenic blood transfusion: results of practice variation in Israel.
    The Israel Medical Association journal : IMAJ, 2001, Volume: 3, Issue:11

    Topics: Aprotinin; Attitude of Health Personnel; Biomedical Technology; Blood Loss, Surgical; Blood Transfus

2001